VINnews · Jul 30, 2026
VINnews — photo status
*Israel Begins World’s First Clinical Trial of Experimental RNA Therapy for Pancreatic Cancer* TEL AVIV (VINnews)-Tel Aviv Sourasky Medical Center has become the first site worldwide to begin recruiting patients for a Phase 2/3 clinical trial of SIL204, an investigational RNA-based treatment for pancreatic cancer developed by Israeli biotech company Silexion Therapeutics. *READ MORE*👉👉 https://vinnews.com/2026/07/30/israel-begins-worlds-first-clinical-trial-of-experimental-rna-therapy-for-pancreatic-cancer/ --- 🌎 Join the VINnews WhatsApp Group:👉 https://chat.whatsapp.com/Gb681opxvSiERstcyfXSyx?mode=wwc
More from VINnews
- VINnewsSep 6, 2026 · Jewish Baby’s Death Renews Immigration Debate in New Jersey
- VINnewsSep 5, 2026 · 🇺🇸-MAGA Inc. drops $10M into the Texas Senate race to back
- VINnewsSep 5, 2026 · 🇺🇸-Q: Did you expect as Treasury Secretary to be so involv
- VINnewsSep 5, 2026 · 🌐 Website Design Built to Impress! Modern sites that turn v
- VINnewsSep 5, 2026 · Border Police Officer Killed in Netanya Shooting Incident NE
- VINnewsSep 5, 2026 · Report: Netanyahu Took 2 Hours to Reach IDF HQ, 3 Hours to S
